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The formation of protein disulphide bonds in newly
synthesised secretory proteins within the endoplasmic
reticulum (ER) depends on an electron transfer system
in which oxidising equivalents are passed from molecular
oxygen through several carriers within the oxidase Ero1
to protein disulphide isomerase (PDI) and then to the
reduced protein substrate. Recent articles published in
The EMBO Journal highlight a crucial and surprising
feature of the control of this process in mammalian cells;
the activity of the key oxidase Ero1a is downregulated in
oxidising conditions through the formation of a stable
non-catalytic disulphide by a cysteine residue that parti-
cipates in one of the redox active sites within the oxidase
(Appenzeller-Herzog et al, 2008; Baker et al, 2008).
Our current understanding of this pathway, mainly based on
studies on the system in yeast (Gross et al, 2006), is that oxidising
equivalents flow from O2 to a flavin cofactor within Ero1, to a
nearby ‘inner’ dithiol/disulphide active site and from there to an
‘outer’ dithiol/disulphide on the surface of Ero1. Ero1 oxidises the
PDI that in turn delivers oxidising equivalents to newly synthesised
protein substrates. Although we do not know all the details, it is
clear that this is not simply a linear pathway. First, the ER lumen
contains the majority of the mammalian cell’s complement of
oxidised glutathione (GSSG); this is believed to be generated by
an inflow of GSH from the cytosol, which is oxidised by the same
pathway to maintain a high-capacity GSSG/GSH oxidising buffer
system within the ER lumen (Bass et al, 2004). Secondly, the Ero1
system generates H2O2, a powerful oxidant, whose subsequent
action and fate is not understood. And finally, mammalian cells
contain several homologous members of the PDI family that operate
in the pathway of protein maturation within the ER (Ellgaard and
Ruddock, 2005).
Nevertheless, it is clear that (i) oxidising equivalents enter the ER
system through Ero1 (Ero1p in yeast, whereas mammalian cells
contain two forms Ero1a and Ero1b), (ii) these equivalents have
several possible destinations, which may vary over time and with
the cell’s physiological status, including the rate at which it is
synthesising proteins for export and (iii) some control of the
pathway is desirable. The recent articles by Ellgaard’s group
(Appenzeller-Herzog et al, 2008) in Copenhagen and Bulleid’s
group (Baker et al, 2008) in Manchester provide insight into how
this control operates.
Ellgaard’s group used a well-targeted transfection system to
create cell lines overexpressing Ero1a (or Ero1b or mutants of
Ero1a) by 20- to 30-fold; within the cells, these species were in
oxidised states and resulted in greater oxidation of PDI. Yet, despite
their much higher oxidase levels, the cells experienced only mini-
mal oxidative stress, suggesting that the overall pathway is tightly
regulated. Ero1a has 15 Cys residues and exists in a number of
different redox states; it was known previously that these differ in
their complement of ‘long-distance’ disulphide bonds. The
Copenhagen group isolated the form that predominates in the
most oxidising conditions and used enzymic proteolysis and mass
spectrometry to identify the disulphide bonds present. The crucial
disulphide that characterizes this ‘most oxidised’ form was found to
be between Cys residues 94 and 131, which was a surprise, as Cys94
and Cys99 interact to form the ‘outer’ dithiol/disulphide redox-
active site. The result implied that Ero1a Cys131 and reduced PDI
compete to reduce the Cys94–Cys99 active site. This was confirmed
by observing the redox state of the components in response to
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Figure 1 (A) In the absence of a reduced substrate, PDI and the FAD and inner disulphide redox centres of Ero1a are oxidised, the regulatory
C94–C131 disulphide forms and the glutathione buffer is shifted towards GSSG. (B) In the presence of a reduced substrate, some PDI is
converted to the reduced form, which reduces the regulatory disulphide; reducing equivalents flow from substrate protein to O2, all redox
centres interconvert between the oxidised and reduced state and the glutathione buffer shifts towards GSH.
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altered levels of both PDI and Ero1a under the different conditions.
It appears that Ero1a is present only in the form with a functional
‘outer active site’ when there is ample reduced PDI present to
compete with Cys131; otherwise, the C94-C131 bond forms.
Finally, Ellgaard’s group transfected cells with a mutant Ero1a
lacking Cys 131 (C131A) and hence unable to form the Cys94-
Cys131 disulphide; in these cells, the C94-C99 active site is always
functional, and they found that the redox state in the ER of these
cells was perturbed to be more highly oxidising, especially as
indicated by higher levels of GSSG. They concluded that in normal
cells, the formation of the Cys94–Cys131 disulphide in oxidising
conditions is a regulatory mechanism that turns off Ero1a oxidase
activity until there is demand for disulphide oxidation as indicated
by a high level of reduced PDI. (see Figure 1).
This work is neatly complemented by studies of the system
in vitro carried out by Bulleid’s group. The Manchester team
expressed recombinant Ero1a and mutant versions lacking specific
Cys residues; by studying the purified recombinant proteins, they
determined that Cys131 and Cys94 were essential for making the
‘most oxidised’ form of Ero1a, confirming the identification of this
bond by the Copenhagen group. They also used recombinant Ero1a
to reconstitute the Ero1a/PDI oxidative system in vitro, showing
that the C131A mutant has increased oxidase activity compared
with wild type and shows no lag in activity, whereas the wild type
shows a lag during which the C94–C131 disulphide becomes
reduced. Finally, Bulleid’s group carried out a redox titration
in vitro to measure the standard redox potential of the C94–C131
disulphide and found a value of 275 mV, showing that this is a
strong disulphide bond, which would be reduced only when there is
abundant reduced substrate present.
Taken together, the articles report a general picture in which Ero1a
exists as an oxidised inactive form and is activated only when there
is a ‘demand’ within the ER, which is signalled by the conversion
of PDI to a predominantly reduced form. As summarised by the
Ellgaard team,‘These data reveal a novel regulatory feedback system
where PDI emerges as a central regulator of ER redox homeostasis.’
There are many aspects of the ER oxidative protein folding
system that are still obscure: how hydrogen peroxide generated by
Ero1 is detoxified, how the inward flow of GSH from the cytosol is
controlled, whether and how oxidising equivalents pass to the
numerous members of the PDI family other than PDI itself, what
the significance is of the abundant protein-SSG mixed disulphides in
the system. Nevertheless, these two articles provide a basis for
understanding key aspects of the mechanism by which the flow of
oxidising equivalents from oxygen to nascent secretory poly-
peptides is regulated.
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